Short Interest in The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) Drops By 51.1%

The Carlyle Group Inc. 4.625% Subordinated Notes due 2061 (NASDAQ:CGABL) was the recipient of a significant drop in short interest in February. As of February 15th, there was short interest totalling 11,500 shares, a drop of 51.1% from the January 31st total of 23,500 shares. Based on an average daily trading volume, of 31,500 shares, the short-interest ratio is currently 0.4 days.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Trading Up 0.1 %

Shares of NASDAQ CGABL traded up $0.01 during mid-day trading on Monday, hitting $18.04. 17,439 shares of the stock traded hands, compared to its average volume of 24,627. Carlyle Group Inc. 4.625% Subordinated Notes due 2061 has a twelve month low of $17.48 and a twelve month high of $20.85. The firm has a 50 day simple moving average of $18.17 and a two-hundred day simple moving average of $19.06.

Carlyle Group Inc. 4.625% Subordinated Notes due 2061 Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Saturday, February 15th. Stockholders of record on Saturday, February 1st were issued a dividend of $0.2891 per share. This is a boost from Carlyle Group Inc. 4.625% Subordinated Notes due 2061’s previous quarterly dividend of $0.29. This represents a $1.16 annualized dividend and a dividend yield of 6.41%. The ex-dividend date was Friday, January 31st.

About Carlyle Group Inc. 4.625% Subordinated Notes due 2061

biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system. biohaven obtained licenses from yale university school of medicine and massachusetts general hospital regarding intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders.